Global Oncology Precision Medicine Market Size, Industry Analysis By Segmentations, Top Key Players, Trends, Future Development & Forecast 2024-2035
- PUBLISHED ON
- 3/1/2023
- NO OF PAGES
- 257
- CATEGORY
- Healthcare & Life Sciences
Oncology Precision Medicine market report presents a global overview of market shares, size, statistics, trends, demand, revenue and growth opportunities by key players, regions and countries. This report offers a complete market overview during the past, present, and the forecast period till 2032 which helps to identify future opportunities, risk factors, growing areas. Report also highlight on recent developments, technological innovations, market affecting factors, demographics analysis, demand and supply chain which gives brief strategy of market growth during the forecast period. It also gives in-depth insights on SWOT and PESTLE analysis based on industry segmentations and regional developments.
Market Overview:
The report provides a basic overview of the industry including definitions, classifications, and industry chain structure. The Oncology Precision Medicine market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand, price, revenue and gross margins.
Report Scope:
The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Oncology Precision Medicine manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases. The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment by type, application and region and as a result provides a holistic view of as well as a deep insight into the Oncology Precision Medicine market covering all its essential aspects.
Global Oncology Precision Medicine Market: Segmentations
Global Oncology Precision Medicine Market: By Types
Applied Sciences
Precision Diagnostics
Digital Health and Information Technology
Precision Therapeutics
Global Oncology Precision Medicine Market: By Applications
Breast Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Cervical Cancer
Other Cancer
Global Oncology Precision Medicine Market: Major Players
Abbott Laboratories
Agilent Technologies
Almac
ANGLE plc
Asuragen
BGI Group
Bio-Rad Laboratories
BioMérieux
Bristol Myers Squibb
Roche Holding AG
Gilead Sciences
Illumina
Konica Minolta
LabCorp
MDxHealth
Myriad Genetics
Novartis
OPKO Health
Pacific Biosciences
Quest Diagnostics
Qiagen
Global Oncology Precision Medicine Market: By Regions
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Key Benefits:
• The analysis provides an overview of the factors driving and limiting the growth of the market including trends, structure and others.
• Market estimation for type and geographic segments is derived from the current market scenario and expected market trends.
• Porter’s Five Force Model and SWOT analysis are used to study the global Oncology Precision Medicine market and would help stakeholders make strategic decisions.
• The analysis assists in understanding the strategies adopted by the companies for the growth of this market.
• In-depth analysis of the types of Oncology Precision Medicine would help in identifying future applications in this market.
Reasons to Purchase this Report:
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Objectives of the Study:
• To provide with an exhaustive analysis on the Oncology Precision Medicine Market by Product, By Application, By End User and by Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
Base Year: 2023Market Overview:
The report provides a basic overview of the industry including definitions, classifications, and industry chain structure. The Oncology Precision Medicine market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand, price, revenue and gross margins.
Report Scope:
The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Oncology Precision Medicine manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases. The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment by type, application and region and as a result provides a holistic view of as well as a deep insight into the Oncology Precision Medicine market covering all its essential aspects.
Global Oncology Precision Medicine Market: Segmentations
Global Oncology Precision Medicine Market: By Types
Applied Sciences
Precision Diagnostics
Digital Health and Information Technology
Precision Therapeutics
Global Oncology Precision Medicine Market: By Applications
Breast Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Cervical Cancer
Other Cancer
Global Oncology Precision Medicine Market: Major Players
Abbott Laboratories
Agilent Technologies
Almac
ANGLE plc
Asuragen
BGI Group
Bio-Rad Laboratories
BioMérieux
Bristol Myers Squibb
Roche Holding AG
Gilead Sciences
Illumina
Konica Minolta
LabCorp
MDxHealth
Myriad Genetics
Novartis
OPKO Health
Pacific Biosciences
Quest Diagnostics
Qiagen
Global Oncology Precision Medicine Market: By Regions
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Key Benefits:
• The analysis provides an overview of the factors driving and limiting the growth of the market including trends, structure and others.
• Market estimation for type and geographic segments is derived from the current market scenario and expected market trends.
• Porter’s Five Force Model and SWOT analysis are used to study the global Oncology Precision Medicine market and would help stakeholders make strategic decisions.
• The analysis assists in understanding the strategies adopted by the companies for the growth of this market.
• In-depth analysis of the types of Oncology Precision Medicine would help in identifying future applications in this market.
Reasons to Purchase this Report:
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Objectives of the Study:
• To provide with an exhaustive analysis on the Oncology Precision Medicine Market by Product, By Application, By End User and by Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
Historic Year: 2016-2022
Forecast: 2024-2035
1 Market Overview
1.1 Product Overview and Scope of Oncology Precision Medicine
1.2 Classification of Oncology Precision Medicine by Type
1.2.1 Overview: Global Oncology Precision Medicine Market Size by Type: 2017 Versus 2022 Versus 2032
1.2.2 Global Oncology Precision Medicine Revenue Market Share by Type in 2022
1.2.3 Applied Sciences
1.2.4 Precision Diagnostics
1.2.5 Digital Health and Information Technology
1.2.6 Precision Therapeutics
1.3 Global Oncology Precision Medicine Market by Application
1.3.1 Overview: Global Oncology Precision Medicine Market Size by Application: 2017 Versus 2022 Versus 2032
1.3.2 Breast Cancer
1.3.3 Lung Cancer
1.3.4 Colorectal Cancer
1.3.5 Prostate Cancer
1.3.6 Cervical Cancer
1.3.7 Other Cancer
1.4 Global Oncology Precision Medicine Market Size & Forecast
1.5 Global Oncology Precision Medicine Market Size and Forecast by Region
1.5.1 Global Oncology Precision Medicine Market Size by Region: 2017 VS 2022 VS 2032
1.5.2 Global Oncology Precision Medicine Market Size by Region, (2016-2021)
1.5.3 North America Oncology Precision Medicine Market Size and Prospect (2017-2032)
1.5.4 Europe Oncology Precision Medicine Market Size and Prospect (2017-2032)
1.5.5 Asia-Pacific Oncology Precision Medicine Market Size and Prospect (2017-2032)
1.5.6 South America Oncology Precision Medicine Market Size and Prospect (2017-2032)
1.5.7 Middle East and Africa Oncology Precision Medicine Market Size and Prospect (2017-2032)
1.6 Market Drivers, Restraints and Trends
1.6.1 Oncology Precision Medicine Market Drivers
1.6.2 Oncology Precision Medicine Market Restraints
1.6.3 Oncology Precision Medicine Trends Analysis
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Oncology Precision Medicine Product and Solutions
2.1.4 Abbott Laboratories Oncology Precision Medicine Revenue, Gross Margin and Market Share (2017-2022)
2.1.5 Abbott Laboratories Recent Developments and Future Plans
2.2 Agilent Technologies
2.2.1 Agilent Technologies Details
2.2.2 Agilent Technologies Major Business
2.2.3 Agilent Technologies Oncology Precision Medicine Product and Solutions
2.2.4 Agilent Technologies Oncology Precision Medicine Revenue, Gross Margin and Market Share (2017-2022)
2.2.5 Agilent Technologies Recent Developments and Future Plans
2.3 Almac
2.3.1 Almac Details
2.3.2 Almac Major Business
2.3.3 Almac Oncology Precision Medicine Product and Solutions
2.3.4 Almac Oncology Precision Medicine Revenue, Gross Margin and Market Share (2017-2022)
2.3.5 Almac Recent Developments and Future Plans
2.4 ANGLE plc
2.4.1 ANGLE plc Details
2.4.2 ANGLE plc Major Business
2.4.3 ANGLE plc Oncology Precision Medicine Product and Solutions
2.4.4 ANGLE plc Oncology Precision Medicine Revenue, Gross Margin and Market Share (2017-2022)
2.4.5 ANGLE plc Recent Developments and Future Plans
2.5 Asuragen
2.5.1 Asuragen Details
2.5.2 Asuragen Major Business
2.5.3 Asuragen Oncology Precision Medicine Product and Solutions
2.5.4 Asuragen Oncology Precision Medicine Revenue, Gross Margin and Market Share (2017-2022)
2.5.5 Asuragen Recent Developments and Future Plans
2.6 BGI Group
2.6.1 BGI Group Details
2.6.2 BGI Group Major Business
2.6.3 BGI Group Oncology Precision Medicine Product and Solutions
2.6.4 BGI Group Oncology Precision Medicine Revenue, Gross Margin and Market Share (2017-2022)
2.6.5 BGI Group Recent Developments and Future Plans
2.7 Bio-Rad Laboratories
2.7.1 Bio-Rad Laboratories Details
2.7.2 Bio-Rad Laboratories Major Business
2.7.3 Bio-Rad Laboratories Oncology Precision Medicine Product and Solutions
2.7.4 Bio-Rad Laboratories Oncology Precision Medicine Revenue, Gross Margin and Market Share (2017-2022)
2.7.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.8 BioMérieux
2.8.1 BioMérieux Details
2.8.2 BioMérieux Major Business
2.8.3 BioMérieux Oncology Precision Medicine Product and Solutions
2.8.4 BioMérieux Oncology Precision Medicine Revenue, Gross Margin and Market Share (2017-2022)
2.8.5 BioMérieux Recent Developments and Future Plans
2.9 Bristol Myers Squibb
2.9.1 Bristol Myers Squibb Details
2.9.2 Bristol Myers Squibb Major Business
2.9.3 Bristol Myers Squibb Oncology Precision Medicine Product and Solutions
2.9.4 Bristol Myers Squibb Oncology Precision Medicine Revenue, Gross Margin and Market Share (2017-2022)
2.9.5 Bristol Myers Squibb Recent Developments and Future Plans
2.10 Roche Holding AG
2.10.1 Roche Holding AG Details
2.10.2 Roche Holding AG Major Business
2.10.3 Roche Holding AG Oncology Precision Medicine Product and Solutions
2.10.4 Roche Holding AG Oncology Precision Medicine Revenue, Gross Margin and Market Share (2017-2022)
2.10.5 Roche Holding AG Recent Developments and Future Plans
2.11 Gilead Sciences
2.11.1 Gilead Sciences Details
2.11.2 Gilead Sciences Major Business
2.11.3 Gilead Sciences Oncology Precision Medicine Product and Solutions
2.11.4 Gilead Sciences Oncology Precision Medicine Revenue, Gross Margin and Market Share (2017-2022)
2.11.5 Gilead Sciences Recent Developments and Future Plans
2.12 Illumina
2.12.1 Illumina Details
2.12.2 Illumina Major Business
2.12.3 Illumina Oncology Precision Medicine Product and Solutions
2.12.4 Illumina Oncology Precision Medicine Revenue, Gross Margin and Market Share (2017-2022)
2.12.5 Illumina Recent Developments and Future Plans
2.13 Konica Minolta
2.13.1 Konica Minolta Details
2.13.2 Konica Minolta Major Business
2.13.3 Konica Minolta Oncology Precision Medicine Product and Solutions
2.13.4 Konica Minolta Oncology Precision Medicine Revenue, Gross Margin and Market Share (2017-2022)
2.13.5 Konica Minolta Recent Developments and Future Plans
2.14 LabCorp
2.14.1 LabCorp Details
2.14.2 LabCorp Major Business
2.14.3 LabCorp Oncology Precision Medicine Product and Solutions
2.14.4 LabCorp Oncology Precision Medicine Revenue, Gross Margin and Market Share (2017-2022)
2.14.5 LabCorp Recent Developments and Future Plans
2.15 MDxHealth
2.15.1 MDxHealth Details
2.15.2 MDxHealth Major Business
2.15.3 MDxHealth Oncology Precision Medicine Product and Solutions
2.15.4 MDxHealth Oncology Precision Medicine Revenue, Gross Margin and Market Share (2017-2022)
2.15.5 MDxHealth Recent Developments and Future Plans
2.16 Myriad Genetics
2.16.1 Myriad Genetics Details
2.16.2 Myriad Genetics Major Business
2.16.3 Myriad Genetics Oncology Precision Medicine Product and Solutions
2.16.4 Myriad Genetics Oncology Precision Medicine Revenue, Gross Margin and Market Share (2017-2022)
2.16.5 Myriad Genetics Recent Developments and Future Plans
2.17 Novartis
2.17.1 Novartis Details
2.17.2 Novartis Major Business
2.17.3 Novartis Oncology Precision Medicine Product and Solutions
2.17.4 Novartis Oncology Precision Medicine Revenue, Gross Margin and Market Share (2017-2022)
2.17.5 Novartis Recent Developments and Future Plans
2.18 OPKO Health
2.18.1 OPKO Health Details
2.18.2 OPKO Health Major Business
2.18.3 OPKO Health Oncology Precision Medicine Product and Solutions
2.18.4 OPKO Health Oncology Precision Medicine Revenue, Gross Margin and Market Share (2017-2022)
2.18.5 OPKO Health Recent Developments and Future Plans
2.19 Pacific Biosciences
2.19.1 Pacific Biosciences Details
2.19.2 Pacific Biosciences Major Business
2.19.3 Pacific Biosciences Oncology Precision Medicine Product and Solutions
2.19.4 Pacific Biosciences Oncology Precision Medicine Revenue, Gross Margin and Market Share (2017-2022)
2.19.5 Pacific Biosciences Recent Developments and Future Plans
2.20 Quest Diagnostics
2.20.1 Quest Diagnostics Details
2.20.2 Quest Diagnostics Major Business
2.20.3 Quest Diagnostics Oncology Precision Medicine Product and Solutions
2.20.4 Quest Diagnostics Oncology Precision Medicine Revenue, Gross Margin and Market Share (2017-2022)
2.20.5 Quest Diagnostics Recent Developments and Future Plans
2.21 Qiagen
2.21.1 Qiagen Details
2.21.2 Qiagen Major Business
2.21.3 Qiagen Oncology Precision Medicine Product and Solutions
2.21.4 Qiagen Oncology Precision Medicine Revenue, Gross Margin and Market Share (2017-2022)
2.21.5 Qiagen Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Oncology Precision Medicine Revenue and Share by Players (2017-2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Oncology Precision Medicine Players Market Share
3.2.2 Top 10 Oncology Precision Medicine Players Market Share
3.2.3 Market Competition Trend
3.3 Oncology Precision Medicine Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Oncology Precision Medicine Revenue and Market Share by Type (2016-2021)
4.2 Global Oncology Precision Medicine Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Oncology Precision Medicine Revenue Market Share by Application (2016-2021)
5.2 Oncology Precision Medicine Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Oncology Precision Medicine Revenue by Type (2017-2032)
6.2 North America Oncology Precision Medicine Revenue by Application (2017-2032)
6.3 North America Oncology Precision Medicine Market Size by Country
6.3.1 North America Oncology Precision Medicine Revenue by Country (2017-2032)
6.3.2 United States Oncology Precision Medicine Market Size and Forecast (2017-2032)
6.3.3 Canada Oncology Precision Medicine Market Size and Forecast (2017-2032)
6.3.4 Mexico Oncology Precision Medicine Market Size and Forecast (2017-2032)
7 Europe by Country, by Type, and by Application
7.1 Europe Oncology Precision Medicine Revenue by Type (2017-2032)
7.2 Europe Oncology Precision Medicine Revenue by Application (2017-2032)
7.3 Europe Oncology Precision Medicine Market Size by Country
7.3.1 Europe Oncology Precision Medicine Revenue by Country (2017-2032)
7.3.2 Germany Oncology Precision Medicine Market Size and Forecast (2017-2032)
7.3.3 France Oncology Precision Medicine Market Size and Forecast (2017-2032)
7.3.4 United Kingdom Oncology Precision Medicine Market Size and Forecast (2017-2032)
7.3.5 Russia Oncology Precision Medicine Market Size and Forecast (2017-2032)
7.3.6 Italy Oncology Precision Medicine Market Size and Forecast (2017-2032)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Oncology Precision Medicine Revenue by Type (2017-2032)
8.2 Asia-Pacific Oncology Precision Medicine Revenue by Application (2017-2032)
8.3 Asia-Pacific Oncology Precision Medicine Market Size by Region
8.3.1 Asia-Pacific Oncology Precision Medicine Revenue by Region (2017-2032)
8.3.2 China Oncology Precision Medicine Market Size and Forecast (2017-2032)
8.3.3 Japan Oncology Precision Medicine Market Size and Forecast (2017-2032)
8.3.4 South Korea Oncology Precision Medicine Market Size and Forecast (2017-2032)
8.3.5 India Oncology Precision Medicine Market Size and Forecast (2017-2032)
8.3.6 Southeast Asia Oncology Precision Medicine Market Size and Forecast (2017-2032)
8.3.7 Australia Oncology Precision Medicine Market Size and Forecast (2017-2032)
9 South America by Country, by Type, and by Application
9.1 South America Oncology Precision Medicine Revenue by Type (2017-2032)
9.2 South America Oncology Precision Medicine Revenue by Application (2017-2032)
9.3 South America Oncology Precision Medicine Market Size by Country
9.3.1 South America Oncology Precision Medicine Revenue by Country (2017-2032)
9.3.2 Brazil Oncology Precision Medicine Market Size and Forecast (2017-2032)
9.3.3 Argentina Oncology Precision Medicine Market Size and Forecast (2017-2032)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Oncology Precision Medicine Revenue by Type (2017-2032)
10.2 Middle East & Africa Oncology Precision Medicine Revenue by Application (2017-2032)
10.3 Middle East & Africa Oncology Precision Medicine Market Size by Country
10.3.1 Middle East & Africa Oncology Precision Medicine Revenue by Country (2017-2032)
10.3.2 Turkey Oncology Precision Medicine Market Size and Forecast (2017-2032)
10.3.3 Saudi Arabia Oncology Precision Medicine Market Size and Forecast (2017-2032)
10.3.4 UAE Oncology Precision Medicine Market Size and Forecast (2017-2032)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Product Overview and Scope of Oncology Precision Medicine
1.2 Classification of Oncology Precision Medicine by Type
1.2.1 Overview: Global Oncology Precision Medicine Market Size by Type: 2017 Versus 2022 Versus 2032
1.2.2 Global Oncology Precision Medicine Revenue Market Share by Type in 2022
1.2.3 Applied Sciences
1.2.4 Precision Diagnostics
1.2.5 Digital Health and Information Technology
1.2.6 Precision Therapeutics
1.3 Global Oncology Precision Medicine Market by Application
1.3.1 Overview: Global Oncology Precision Medicine Market Size by Application: 2017 Versus 2022 Versus 2032
1.3.2 Breast Cancer
1.3.3 Lung Cancer
1.3.4 Colorectal Cancer
1.3.5 Prostate Cancer
1.3.6 Cervical Cancer
1.3.7 Other Cancer
1.4 Global Oncology Precision Medicine Market Size & Forecast
1.5 Global Oncology Precision Medicine Market Size and Forecast by Region
1.5.1 Global Oncology Precision Medicine Market Size by Region: 2017 VS 2022 VS 2032
1.5.2 Global Oncology Precision Medicine Market Size by Region, (2016-2021)
1.5.3 North America Oncology Precision Medicine Market Size and Prospect (2017-2032)
1.5.4 Europe Oncology Precision Medicine Market Size and Prospect (2017-2032)
1.5.5 Asia-Pacific Oncology Precision Medicine Market Size and Prospect (2017-2032)
1.5.6 South America Oncology Precision Medicine Market Size and Prospect (2017-2032)
1.5.7 Middle East and Africa Oncology Precision Medicine Market Size and Prospect (2017-2032)
1.6 Market Drivers, Restraints and Trends
1.6.1 Oncology Precision Medicine Market Drivers
1.6.2 Oncology Precision Medicine Market Restraints
1.6.3 Oncology Precision Medicine Trends Analysis
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Oncology Precision Medicine Product and Solutions
2.1.4 Abbott Laboratories Oncology Precision Medicine Revenue, Gross Margin and Market Share (2017-2022)
2.1.5 Abbott Laboratories Recent Developments and Future Plans
2.2 Agilent Technologies
2.2.1 Agilent Technologies Details
2.2.2 Agilent Technologies Major Business
2.2.3 Agilent Technologies Oncology Precision Medicine Product and Solutions
2.2.4 Agilent Technologies Oncology Precision Medicine Revenue, Gross Margin and Market Share (2017-2022)
2.2.5 Agilent Technologies Recent Developments and Future Plans
2.3 Almac
2.3.1 Almac Details
2.3.2 Almac Major Business
2.3.3 Almac Oncology Precision Medicine Product and Solutions
2.3.4 Almac Oncology Precision Medicine Revenue, Gross Margin and Market Share (2017-2022)
2.3.5 Almac Recent Developments and Future Plans
2.4 ANGLE plc
2.4.1 ANGLE plc Details
2.4.2 ANGLE plc Major Business
2.4.3 ANGLE plc Oncology Precision Medicine Product and Solutions
2.4.4 ANGLE plc Oncology Precision Medicine Revenue, Gross Margin and Market Share (2017-2022)
2.4.5 ANGLE plc Recent Developments and Future Plans
2.5 Asuragen
2.5.1 Asuragen Details
2.5.2 Asuragen Major Business
2.5.3 Asuragen Oncology Precision Medicine Product and Solutions
2.5.4 Asuragen Oncology Precision Medicine Revenue, Gross Margin and Market Share (2017-2022)
2.5.5 Asuragen Recent Developments and Future Plans
2.6 BGI Group
2.6.1 BGI Group Details
2.6.2 BGI Group Major Business
2.6.3 BGI Group Oncology Precision Medicine Product and Solutions
2.6.4 BGI Group Oncology Precision Medicine Revenue, Gross Margin and Market Share (2017-2022)
2.6.5 BGI Group Recent Developments and Future Plans
2.7 Bio-Rad Laboratories
2.7.1 Bio-Rad Laboratories Details
2.7.2 Bio-Rad Laboratories Major Business
2.7.3 Bio-Rad Laboratories Oncology Precision Medicine Product and Solutions
2.7.4 Bio-Rad Laboratories Oncology Precision Medicine Revenue, Gross Margin and Market Share (2017-2022)
2.7.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.8 BioMérieux
2.8.1 BioMérieux Details
2.8.2 BioMérieux Major Business
2.8.3 BioMérieux Oncology Precision Medicine Product and Solutions
2.8.4 BioMérieux Oncology Precision Medicine Revenue, Gross Margin and Market Share (2017-2022)
2.8.5 BioMérieux Recent Developments and Future Plans
2.9 Bristol Myers Squibb
2.9.1 Bristol Myers Squibb Details
2.9.2 Bristol Myers Squibb Major Business
2.9.3 Bristol Myers Squibb Oncology Precision Medicine Product and Solutions
2.9.4 Bristol Myers Squibb Oncology Precision Medicine Revenue, Gross Margin and Market Share (2017-2022)
2.9.5 Bristol Myers Squibb Recent Developments and Future Plans
2.10 Roche Holding AG
2.10.1 Roche Holding AG Details
2.10.2 Roche Holding AG Major Business
2.10.3 Roche Holding AG Oncology Precision Medicine Product and Solutions
2.10.4 Roche Holding AG Oncology Precision Medicine Revenue, Gross Margin and Market Share (2017-2022)
2.10.5 Roche Holding AG Recent Developments and Future Plans
2.11 Gilead Sciences
2.11.1 Gilead Sciences Details
2.11.2 Gilead Sciences Major Business
2.11.3 Gilead Sciences Oncology Precision Medicine Product and Solutions
2.11.4 Gilead Sciences Oncology Precision Medicine Revenue, Gross Margin and Market Share (2017-2022)
2.11.5 Gilead Sciences Recent Developments and Future Plans
2.12 Illumina
2.12.1 Illumina Details
2.12.2 Illumina Major Business
2.12.3 Illumina Oncology Precision Medicine Product and Solutions
2.12.4 Illumina Oncology Precision Medicine Revenue, Gross Margin and Market Share (2017-2022)
2.12.5 Illumina Recent Developments and Future Plans
2.13 Konica Minolta
2.13.1 Konica Minolta Details
2.13.2 Konica Minolta Major Business
2.13.3 Konica Minolta Oncology Precision Medicine Product and Solutions
2.13.4 Konica Minolta Oncology Precision Medicine Revenue, Gross Margin and Market Share (2017-2022)
2.13.5 Konica Minolta Recent Developments and Future Plans
2.14 LabCorp
2.14.1 LabCorp Details
2.14.2 LabCorp Major Business
2.14.3 LabCorp Oncology Precision Medicine Product and Solutions
2.14.4 LabCorp Oncology Precision Medicine Revenue, Gross Margin and Market Share (2017-2022)
2.14.5 LabCorp Recent Developments and Future Plans
2.15 MDxHealth
2.15.1 MDxHealth Details
2.15.2 MDxHealth Major Business
2.15.3 MDxHealth Oncology Precision Medicine Product and Solutions
2.15.4 MDxHealth Oncology Precision Medicine Revenue, Gross Margin and Market Share (2017-2022)
2.15.5 MDxHealth Recent Developments and Future Plans
2.16 Myriad Genetics
2.16.1 Myriad Genetics Details
2.16.2 Myriad Genetics Major Business
2.16.3 Myriad Genetics Oncology Precision Medicine Product and Solutions
2.16.4 Myriad Genetics Oncology Precision Medicine Revenue, Gross Margin and Market Share (2017-2022)
2.16.5 Myriad Genetics Recent Developments and Future Plans
2.17 Novartis
2.17.1 Novartis Details
2.17.2 Novartis Major Business
2.17.3 Novartis Oncology Precision Medicine Product and Solutions
2.17.4 Novartis Oncology Precision Medicine Revenue, Gross Margin and Market Share (2017-2022)
2.17.5 Novartis Recent Developments and Future Plans
2.18 OPKO Health
2.18.1 OPKO Health Details
2.18.2 OPKO Health Major Business
2.18.3 OPKO Health Oncology Precision Medicine Product and Solutions
2.18.4 OPKO Health Oncology Precision Medicine Revenue, Gross Margin and Market Share (2017-2022)
2.18.5 OPKO Health Recent Developments and Future Plans
2.19 Pacific Biosciences
2.19.1 Pacific Biosciences Details
2.19.2 Pacific Biosciences Major Business
2.19.3 Pacific Biosciences Oncology Precision Medicine Product and Solutions
2.19.4 Pacific Biosciences Oncology Precision Medicine Revenue, Gross Margin and Market Share (2017-2022)
2.19.5 Pacific Biosciences Recent Developments and Future Plans
2.20 Quest Diagnostics
2.20.1 Quest Diagnostics Details
2.20.2 Quest Diagnostics Major Business
2.20.3 Quest Diagnostics Oncology Precision Medicine Product and Solutions
2.20.4 Quest Diagnostics Oncology Precision Medicine Revenue, Gross Margin and Market Share (2017-2022)
2.20.5 Quest Diagnostics Recent Developments and Future Plans
2.21 Qiagen
2.21.1 Qiagen Details
2.21.2 Qiagen Major Business
2.21.3 Qiagen Oncology Precision Medicine Product and Solutions
2.21.4 Qiagen Oncology Precision Medicine Revenue, Gross Margin and Market Share (2017-2022)
2.21.5 Qiagen Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Oncology Precision Medicine Revenue and Share by Players (2017-2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Oncology Precision Medicine Players Market Share
3.2.2 Top 10 Oncology Precision Medicine Players Market Share
3.2.3 Market Competition Trend
3.3 Oncology Precision Medicine Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Oncology Precision Medicine Revenue and Market Share by Type (2016-2021)
4.2 Global Oncology Precision Medicine Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Oncology Precision Medicine Revenue Market Share by Application (2016-2021)
5.2 Oncology Precision Medicine Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Oncology Precision Medicine Revenue by Type (2017-2032)
6.2 North America Oncology Precision Medicine Revenue by Application (2017-2032)
6.3 North America Oncology Precision Medicine Market Size by Country
6.3.1 North America Oncology Precision Medicine Revenue by Country (2017-2032)
6.3.2 United States Oncology Precision Medicine Market Size and Forecast (2017-2032)
6.3.3 Canada Oncology Precision Medicine Market Size and Forecast (2017-2032)
6.3.4 Mexico Oncology Precision Medicine Market Size and Forecast (2017-2032)
7 Europe by Country, by Type, and by Application
7.1 Europe Oncology Precision Medicine Revenue by Type (2017-2032)
7.2 Europe Oncology Precision Medicine Revenue by Application (2017-2032)
7.3 Europe Oncology Precision Medicine Market Size by Country
7.3.1 Europe Oncology Precision Medicine Revenue by Country (2017-2032)
7.3.2 Germany Oncology Precision Medicine Market Size and Forecast (2017-2032)
7.3.3 France Oncology Precision Medicine Market Size and Forecast (2017-2032)
7.3.4 United Kingdom Oncology Precision Medicine Market Size and Forecast (2017-2032)
7.3.5 Russia Oncology Precision Medicine Market Size and Forecast (2017-2032)
7.3.6 Italy Oncology Precision Medicine Market Size and Forecast (2017-2032)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Oncology Precision Medicine Revenue by Type (2017-2032)
8.2 Asia-Pacific Oncology Precision Medicine Revenue by Application (2017-2032)
8.3 Asia-Pacific Oncology Precision Medicine Market Size by Region
8.3.1 Asia-Pacific Oncology Precision Medicine Revenue by Region (2017-2032)
8.3.2 China Oncology Precision Medicine Market Size and Forecast (2017-2032)
8.3.3 Japan Oncology Precision Medicine Market Size and Forecast (2017-2032)
8.3.4 South Korea Oncology Precision Medicine Market Size and Forecast (2017-2032)
8.3.5 India Oncology Precision Medicine Market Size and Forecast (2017-2032)
8.3.6 Southeast Asia Oncology Precision Medicine Market Size and Forecast (2017-2032)
8.3.7 Australia Oncology Precision Medicine Market Size and Forecast (2017-2032)
9 South America by Country, by Type, and by Application
9.1 South America Oncology Precision Medicine Revenue by Type (2017-2032)
9.2 South America Oncology Precision Medicine Revenue by Application (2017-2032)
9.3 South America Oncology Precision Medicine Market Size by Country
9.3.1 South America Oncology Precision Medicine Revenue by Country (2017-2032)
9.3.2 Brazil Oncology Precision Medicine Market Size and Forecast (2017-2032)
9.3.3 Argentina Oncology Precision Medicine Market Size and Forecast (2017-2032)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Oncology Precision Medicine Revenue by Type (2017-2032)
10.2 Middle East & Africa Oncology Precision Medicine Revenue by Application (2017-2032)
10.3 Middle East & Africa Oncology Precision Medicine Market Size by Country
10.3.1 Middle East & Africa Oncology Precision Medicine Revenue by Country (2017-2032)
10.3.2 Turkey Oncology Precision Medicine Market Size and Forecast (2017-2032)
10.3.3 Saudi Arabia Oncology Precision Medicine Market Size and Forecast (2017-2032)
10.3.4 UAE Oncology Precision Medicine Market Size and Forecast (2017-2032)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Quality Assurance Process
- We Market Research’s Quality Assurance program strives to deliver superior value to our clients.
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
- Project kickoff meeting with client
- Conduct frequent client communications
- Form project steering committee
- Assign a senior SR executive as QA Executive
- Conduct internal editorial & quality reviews of project deliverables
- Certify project staff in SR methodologies & standards
- Monitor client satisfaction
- Monitor realized value post-project
Case Study- Automotive Sector
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached Straits Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
Solution
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
Market Estimates and Forecast
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Case Study- ICT Sector
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2028.
}})
Pricing
Select a license type that suits your business needs
Single User Access
US $3950
Only Three Thousand Nine Hundred Fifty US dollar
- 1 User access
- 15% Additional Free Customization
- Free Unlimited post-sale support
- 100% Service Guarantee until achievement of ROI
Multi User Cost
US $4950
Only Four Thousand Nine Hundred Fifty US dollar
- 5 Users access
- 25% Additional Free Customization
- Access Report summaries for Free
- Guaranteed service
- Dedicated Account Manager
- Discount of 20% on next purchase
- Get personalized market brief from Lead Author
- Printing of Report permitted
- Discount of 20% on next purchase
- 100% Service Guarantee until achievement of ROI
Enterprise User Cost
US $5950
Only Five Thousand Nine Hundred Fifty US dollar
- Unlimited User Access
- 30% Additional Free Customization
- Exclusive Previews to latest or upcoming reports
- Discount of 30% on next purchase
- 100% Service Guarantee until achievement of ROI